GRTX logo

Galera Therapeutics, Inc. Common Stock


GRTX: Galera Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer. Its lead product candidate, GC4419, is a small molecule dismutase mimetic developed for the reduction of severe oral mucositis, or SOM.


Show GRTX Financials

Consumer Interest
SEC Filings

Recent trades of GRTX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by GRTX's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Chromatography of metal complexes Aug. 19, 2014
  • Patent Title: Super-oxide dismutase mimetics Jul. 16, 2013
  • Patent Title: Chromatography of metal complexes May. 21, 2013
  • Patent Title: Chromatography of metal complexes Sep. 11, 2012
  • Patent Title: Polyethylene glycolated superoxide dismutase mimetics Jul. 10, 2012
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of GRTX in WallStreetBets Daily Discussion


Recent insights relating to GRTX

CNBC Recommendations

Recent picks made for GRTX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GRTX

Corporate Flights

Flights by private jets registered to GRTX